{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T03:23:43Z","timestamp":1792725823983,"version":"4.5.0"},"reference-count":78,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2016,3,1]],"date-time":"2016-03-01T00:00:00Z","timestamp":1456790400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2015,11,5]],"date-time":"2015-11-05T00:00:00Z","timestamp":1446681600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["journalofclinicalvirology.com","clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Clinical Virology"],"published-print":{"date-parts":[[2016,3]]},"DOI":"10.1016\/j.jcv.2015.10.027","type":"journal-article","created":{"date-parts":[[2015,11,6]],"date-time":"2015-11-06T05:24:22Z","timestamp":1446787462000},"page":"S40-S48","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":78,"special_numbering":"S1","title":["A review of the clinical performance of the Aptima HPV assay"],"prefix":"10.1016","volume":"76","author":[{"given":"Juliane","family":"Haedicke","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Iftner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jcv.2015.10.027_bib0005","doi-asserted-by":"crossref","first-page":"4680","DOI":"10.1073\/pnas.83.13.4680","article-title":"Transcription of human papillomavirus type 16 early genes in a cervical cancer and a cancer-derived cell line and identification of the E7 protein","volume":"83","author":"Smotkin","year":"1986","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.jcv.2015.10.027_bib0010","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1002\/1096-9071(200010)62:2<251::AID-JMV18>3.0.CO;2-V","article-title":"Ubiquitous presence of E6 and E7 transcripts in human papillomavirus-positive cervical carcinomas regardless of its type","volume":"62","author":"Nakagawa","year":"2000","journal-title":"J. Med. Virol."},{"key":"10.1016\/j.jcv.2015.10.027_bib0015","doi-asserted-by":"crossref","first-page":"2536","DOI":"10.1158\/1055-9965.EPI-08-0306","article-title":"Human papillomavirus mRNA and p16 detection as biomarkers for the improved diagnosis of cervical neoplasia","volume":"17","author":"Cuschieri","year":"2008","journal-title":"Cancer Epidemiol. Biomarkers Prev."},{"key":"10.1016\/j.jcv.2015.10.027_bib0020","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1002\/jmv.20153","article-title":"Detection of high-risk human papillomavirus E6 and E7 oncogene transcripts in cervical scrapes by nested RT-polymerase chain reaction","volume":"74","author":"Sotlar","year":"2004","journal-title":"J. Med. Virol."},{"key":"10.1016\/j.jcv.2015.10.027_bib0025","doi-asserted-by":"crossref","first-page":"3176","DOI":"10.1128\/JCM.42.7.3176-3184.2004","article-title":"Detection and typing of human papillomavirus by e6 nested multiplex PCR","volume":"42","author":"Sotlar","year":"2004","journal-title":"J. Clin. Microbiol."},{"key":"10.1016\/j.jcv.2015.10.027_bib0030","doi-asserted-by":"crossref","first-page":"2643","DOI":"10.1128\/JCM.02570-10","article-title":"Sensitivity, specificity, and clinical value of human papillomavirus (HPV) E6\/E7 mRNA assay as a triage test for cervical cytology and HPV DNA test","volume":"49","author":"Benevolo","year":"2011","journal-title":"J. Clin. Microbiol."},{"key":"10.1016\/j.jcv.2015.10.027_bib0035","doi-asserted-by":"crossref","first-page":"2779","DOI":"10.1128\/JCM.00382-10","article-title":"Clinical performance of the PreTect HPV-Proofer E6\/E7 mRNA assay in comparison with that of the Hybrid Capture 2 test for identification of women at risk of cervical cancer","volume":"48","author":"Ratnam","year":"2010","journal-title":"J. Clin. Microbiol."},{"key":"10.1016\/j.jcv.2015.10.027_bib0040","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1002\/ijc.27636","article-title":"The APTIMA HPV assay versus the Hybrid Capture 2 test in triage of women with ASC-US or LSIL cervical cytology: a meta-analysis of the diagnostic accuracy","volume":"132","author":"Arbyn","year":"2013","journal-title":"Int. J. Cancer"},{"issue":"Suppl. 5","key":"10.1016\/j.jcv.2015.10.027_bib0045","doi-asserted-by":"crossref","first-page":"F88","DOI":"10.1016\/j.vaccine.2012.06.095","article-title":"Evidence regarding human papillomavirus testing in secondary prevention of cervical cancer","volume":"30","author":"Arbyn","year":"2012","journal-title":"Vaccine"},{"key":"10.1016\/j.jcv.2015.10.027_bib0050","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1002\/cncy.21325","article-title":"Triage of women with minor abnormal cervical cytology: meta-analysis of the accuracy of an assay targeting messenger ribonucleic acid of 5 high-risk human papillomavirus types","volume":"121","author":"Verdoodt","year":"2013","journal-title":"Cancer Cytopathol."},{"key":"10.1016\/j.jcv.2015.10.027_bib0055","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1002\/ijc.22527","article-title":"Human papillomavirus type distribution in invasive cervical cancer and high-grade cervical lesions: a meta-analysis update","volume":"121","author":"Smith","year":"2007","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.jcv.2015.10.027_bib0060","doi-asserted-by":"crossref","first-page":"1611","DOI":"10.1158\/1055-9965.EPI-07-2922","article-title":"A systematic review of the prevalence and attribution of human papillomavirus types among cervical, vaginal, and vulvar precancers and cancers in the United States","volume":"17","author":"Insinga","year":"2008","journal-title":"Cancer Epidemiol. Biomarkers Prev."},{"key":"10.1016\/j.jcv.2015.10.027_bib0065","doi-asserted-by":"crossref","first-page":"e003460","DOI":"10.1136\/bmjopen-2013-003460","article-title":"Comparative effectiveness study on human papillomavirus detection methods used in the cervical cancer screening programme","volume":"4","author":"Nygard","year":"2014","journal-title":"BMJ Open"},{"key":"10.1016\/j.jcv.2015.10.027_bib0070","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1586\/14737159.1.4.445","article-title":"Molecular diagnostic testing for infectious diseases using TMA technology","volume":"1","author":"Hill","year":"2001","journal-title":"Expert Rev. Mol. Diagn."},{"key":"10.1016\/j.jcv.2015.10.027_bib0075","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/0009-8981(90)90304-B","article-title":"Chemiluminescent DNA probes: a comparison of the acridinium ester and dioxetane detection systems and their use in clinical diagnostic assays","volume":"194","author":"Nelson","year":"1990","journal-title":"Clin. Chim. Acta"},{"key":"10.1016\/j.jcv.2015.10.027_bib0080","unstructured":"IARC, 2012, A Review of Human Carcinogens\u2014Biological Agents. IARC Monogr Eval Carcinog Risks Hum. Vol. 100B, 255\u2013313."},{"key":"10.1016\/j.jcv.2015.10.027_bib0085","doi-asserted-by":"crossref","first-page":"1048","DOI":"10.1016\/S1470-2045(10)70230-8","article-title":"Human papillomavirus genotype attribution in invasive cervical cancer: a retrospective cross-sectional worldwide study","volume":"11","author":"de Sanjose","year":"2010","journal-title":"Lancet Oncol."},{"issue":"Suppl. 1","key":"10.1016\/j.jcv.2015.10.027_bib0090","doi-asserted-by":"crossref","first-page":"S39","DOI":"10.1016\/S1386-6532(09)70007-1","article-title":"Analytical characterization of the APTIMA HPV Assay","volume":"45","author":"Dockter","year":"2009","journal-title":"J. Clin. Virol."},{"issue":"Suppl. 1","key":"10.1016\/j.jcv.2015.10.027_bib0095","doi-asserted-by":"crossref","first-page":"S49","DOI":"10.1016\/S1386-6532(09)70008-3","article-title":"Efficiency of the APTIMA HPV Assay for detection of HPV RNA and DNA targets","volume":"45","author":"Getman","year":"2009","journal-title":"J. Clin. Virol."},{"key":"10.1016\/j.jcv.2015.10.027_bib0100","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/j.jviromet.2013.05.013","article-title":"Comparison of the sensitivities of three commercial assays for detection of the high risk HPV types 16, 18 and 45","volume":"193","author":"Cuschieri","year":"2013","journal-title":"J. Virol. Methods"},{"key":"10.1016\/j.jcv.2015.10.027_bib0105","doi-asserted-by":"crossref","first-page":"e90023","DOI":"10.1371\/journal.pone.0090023","article-title":"Triage of HR-HPV positive women with minor cytological abnormalities: a comparison of mRNA testing, HPV DNA testing, and repeat cytology using a 4-year follow-up of a population-based study","volume":"9","author":"Persson","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.jcv.2015.10.027_bib0110","doi-asserted-by":"crossref","first-page":"1448","DOI":"10.1128\/JCM.03624-13","article-title":"Effect of preanalytical processing of ThinPrep specimens on detection of high-risk human papillomavirus by the Aptima HPV assay","volume":"52","author":"Munson","year":"2014","journal-title":"J. Clin. Microbiol."},{"key":"10.1016\/j.jcv.2015.10.027_bib0115","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.jviromet.2015.04.030","article-title":"detection and genotyping by APTIMA HPV using cervical samples","volume":"221","author":"Pyne","year":"2015","journal-title":"J. Virol. Methods"},{"key":"10.1016\/j.jcv.2015.10.027_bib0120","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1097\/OLQ.0000000000000125","article-title":"Evaluation of a new APTIMA specimen collection and transportation kit for high-risk human papillomavirus E6\/E7 messenger RNA in cervical and vaginal samples","volume":"41","author":"Chernesky","year":"2014","journal-title":"Sex. Transm. Dis."},{"key":"10.1016\/j.jcv.2015.10.027_bib0125","article-title":"Comparison of the performance of HPV tests in women with abnormal cytology: results of a study within the NHS cervical screening programme","author":"Moss","year":"2014","journal-title":"Cytopathology"},{"key":"10.1016\/j.jcv.2015.10.027_bib0130","doi-asserted-by":"crossref","first-page":"1456","DOI":"10.1016\/j.ejca.2015.04.012","article-title":"A daunting challenge: human Papillomavirus assays and cytology in primary cervical screening of women below age 30 years","volume":"51","author":"Rebolj","year":"2015","journal-title":"Eur. J. Cancer"},{"key":"10.1016\/j.jcv.2015.10.027_bib0135","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1016\/j.ygyno.2014.10.014","article-title":"Comparison of three human papillomavirus DNA assays and one mRNA assay in women with abnormal cytology","volume":"135","author":"Rebolj","year":"2014","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.jcv.2015.10.027_bib0140","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1016\/j.jmoldx.2013.04.002","article-title":"Prevalence of Human Papillomavirus infection in unselected SurePath samples using the APTIMA HPV mRNA assay","volume":"15","author":"Rebolj","year":"2013","journal-title":"J. Mol. Diagn."},{"key":"10.1016\/j.jcv.2015.10.027_bib0145","unstructured":"Aptima Specimen Transfer Kit (AW-11585-001 Rev. 002). Package insert. Hologic Inc. San Diego, CA 2015."},{"key":"10.1016\/j.jcv.2015.10.027_bib0150","doi-asserted-by":"crossref","first-page":"167","DOI":"10.2147\/DHPS.S37273","article-title":"Limitations of widely used high-risk human papillomavirus laboratory-developed testing in cervical cancer screening","volume":"4","author":"Naryshkin","year":"2012","journal-title":"Drug Healthcare Patient Saf."},{"key":"10.1016\/j.jcv.2015.10.027_bib0155","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1002\/ijc.24010","article-title":"Guidelines for human papillomavirus DNA test requirements for primary cervical cancer screening in women 30 years and older","volume":"124","author":"Meijer","year":"2009","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.jcv.2015.10.027_bib0160","doi-asserted-by":"crossref","first-page":"3653","DOI":"10.1128\/JCM.01517-13","article-title":"The Aptima HPV assay fulfills the cross-sectional clinical and reproducibility criteria of international guidelines for human papillomavirus test requirements for cervical screening","volume":"51","author":"Heideman","year":"2013","journal-title":"J. Clin. Microbiol."},{"key":"10.1016\/j.jcv.2015.10.027_bib0165","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1093\/annonc\/mdp471","article-title":"European guidelines for quality assurance in cervical cancer screening. Second edition\u2014summary document","volume":"21","author":"Arbyn","year":"2010","journal-title":"Ann. Oncol."},{"key":"10.1016\/j.jcv.2015.10.027_bib0170","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1309\/AJCPTGD94EVRSJCG","article-title":"American cancer society, American society for colposcopy and cervical pathology, and American society for clinical pathology screening guidelines for the prevention and early detection of cervical cancer","volume":"137","author":"Saslow","year":"2012","journal-title":"Am. J. Clin. Pathol."},{"key":"10.1016\/j.jcv.2015.10.027_bib0175","doi-asserted-by":"crossref","first-page":"1764","DOI":"10.1016\/S0140-6736(07)61450-0","article-title":"Human papillomavirus DNA testing for the detection of cervical intraepithelial neoplasia grade 3 and cancer: 5-year follow-up of a randomised controlled implementation trial","volume":"370","author":"Bulkmans","year":"2007","journal-title":"Lancet"},{"key":"10.1016\/j.jcv.2015.10.027_bib0180","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1016\/S1470-2045(09)70156-1","article-title":"HPV testing in combination with liquid-based cytology in primary cervical screening (ARTISTIC): a randomised controlled trial","volume":"10","author":"Kitchener","year":"2009","journal-title":"Lancet Oncol."},{"key":"10.1016\/j.jcv.2015.10.027_bib0185","doi-asserted-by":"crossref","first-page":"1589","DOI":"10.1056\/NEJMoa073204","article-title":"Human papillomavirus and Papanicolaou tests to screen for cervical cancer","volume":"357","author":"Naucler","year":"2007","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.jcv.2015.10.027_bib0190","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/S1470-2045(09)70360-2","article-title":"Efficacy of human papillomavirus testing for the detection of invasive cervical cancers and cervical intraepithelial neoplasia: a randomised controlled trial","volume":"11","author":"Ronco","year":"2010","journal-title":"Lancet Oncol."},{"key":"10.1016\/j.jcv.2015.10.027_bib0195","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1016\/S1470-2045(06)70731-8","article-title":"Human papillomavirus testing and liquid-based cytology in primary screening of women younger than 35 years: results at recruitment for a randomised controlled trial","volume":"7","author":"Ronco","year":"2006","journal-title":"Lancet Oncol."},{"key":"10.1016\/j.jcv.2015.10.027_bib0200","doi-asserted-by":"crossref","first-page":"880","DOI":"10.1016\/S1470-2045(11)70188-7","article-title":"Performance of carcinogenic human papillomavirus (HPV) testing and HPV16 or HPV18 genotyping for cervical cancer screening of women aged 25 years and older: a subanalysis of the ATHENA study","volume":"12","author":"Castle","year":"2011","journal-title":"Lancet Oncol."},{"key":"10.1016\/j.jcv.2015.10.027_bib0205","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1309\/AJCPZ5JY6FCVNMOT","article-title":"High-risk human papillomavirus testing in women with ASC-US cytology: results from the ATHENA HPV study","volume":"135","author":"Stoler","year":"2011","journal-title":"Am. J. Clin. Pathol."},{"issue":"9","key":"10.1016\/j.jcv.2015.10.027_bib0210","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1016\/j.cmi.2015.04.015","article-title":"Which high-risk HPV assays fulfil criteria for use in primary cervical cancer screening?","volume":"21","author":"Arbyn","year":"2015","journal-title":"Clin. Microbiol. Infect."},{"issue":"533","key":"10.1016\/j.jcv.2015.10.027_bib0215","article-title":"E6\/E7 mRNA testing for human papilloma virus-induced high-grade cervical intraepithelial disease (CIN2\/CIN3): a promising perspective","volume":"9","author":"Origoni","year":"2015","journal-title":"Ecancermedicalscience"},{"key":"10.1016\/j.jcv.2015.10.027_bib0220","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1016\/j.ygyno.2010.11.013","article-title":"HPV mRNA tests for the detection of cervical intraepithelial neoplasia: a systematic review","volume":"120","author":"Burger","year":"2011","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.jcv.2015.10.027_bib0225","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1007\/s13669-013-0040-0","article-title":"HPV-based tests for cervical cancer screening and management of cervical disease","volume":"2","author":"Luhn","year":"2013","journal-title":"Curr. Obstet. Gynecol. Rep."},{"key":"10.1016\/j.jcv.2015.10.027_bib0230","doi-asserted-by":"crossref","first-page":"908","DOI":"10.1038\/bjc.2013.22","article-title":"Comparing the performance of six human papillomavirus tests in a screening population","volume":"108","author":"Cuzick","year":"2013","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.jcv.2015.10.027_bib0235","doi-asserted-by":"crossref","first-page":"1867","DOI":"10.1128\/JCM.00181-12","article-title":"Comparison of seven tests for high-grade cervical intraepithelial neoplasia in women with abnormal smears: the Predictors 2 study","volume":"50","author":"Szarewski","year":"2012","journal-title":"J. Clin. Microbiol."},{"key":"10.1016\/j.jcv.2015.10.027_bib0240","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1016\/j.ygyno.2011.07.024","article-title":"Comparison of different commercial methods for HPV detection in follow-up cytology after ASCUS\/LSIL, prediction of CIN2-3 in follow up biopsies and spontaneous regression of CIN2-3","volume":"123","author":"Ovestad","year":"2011","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.jcv.2015.10.027_bib0245","doi-asserted-by":"crossref","first-page":"1277","DOI":"10.1128\/JCM.03558-14","article-title":"Comparison of human papillomavirus detection by Aptima HPV and cobas HPV tests in a population of women referred for colposcopy following detection of atypical squamous cells of undetermined significance by Pap cytology","volume":"53","author":"Castle","year":"2015","journal-title":"J. Clin. Microbiol."},{"key":"10.1016\/j.jcv.2015.10.027_bib0250","doi-asserted-by":"crossref","first-page":"3763","DOI":"10.1128\/JCM.01928-14","article-title":"Comparative evaluation of three commercial systems for detection of high-risk human papillomavirus in cervical and vaginal ThinPrep PreservCyt samples and correlation with biopsy results","volume":"52","author":"Binnicker","year":"2014","journal-title":"J. Clin. Microbiol."},{"key":"10.1016\/j.jcv.2015.10.027_bib0255","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1159\/000358246","article-title":"Testing of integrated human papillomavirus mRNA decreases colposcopy referrals: could a change in human papillomavirus detection methodology lead to more cost-effective patient care?","volume":"58","author":"Sauter","year":"2014","journal-title":"Acta Cytol."},{"key":"10.1016\/j.jcv.2015.10.027_bib0260","doi-asserted-by":"crossref","first-page":"2509","DOI":"10.1128\/JCM.01013-15","article-title":"Head-to-head comparison of the RNA-based Aptima Human Papillomavirus (HPV) Assay and the DNA-based hybrid capture 2HPV test in a routine screening population of women aged 30 to 60 years in Germany","volume":"53","author":"Iftner","year":"2015","journal-title":"J. Clin. Microbiol."},{"key":"10.1016\/j.jcv.2015.10.027_bib0265","doi-asserted-by":"crossref","first-page":"e0124460","DOI":"10.1371\/journal.pone.0124460","article-title":"Presence of high-risk HPV mRNA in relation to future high-grade lesions among high-risk HPV DNA positive women with minor cytological abnormalities","volume":"10","author":"Johansson","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.jcv.2015.10.027_bib0270","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1002\/cncy.21233","article-title":"Evaluation of p16(INK4a)\/Ki-67 dual stain in comparison with an mRNA human papillomavirus test on liquid-based cytology samples with low-grade squamous intraepithelial lesion","volume":"121","author":"Waldstrom","year":"2013","journal-title":"Cancer cytopathol."},{"key":"10.1016\/j.jcv.2015.10.027_bib0275","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1111\/j.1365-2303.2011.00923.x","article-title":"Comparison of the clinical performance of an HPV mRNA test and an HPV DNA test in triage of atypical squamous cells of undetermined significance (ASC-US)","volume":"23","author":"Waldstrom","year":"2012","journal-title":"Cytopathology"},{"key":"10.1016\/j.jcv.2015.10.027_bib0280","first-page":"346","article-title":"High-risk human papillomavirus E6\/E7 mRNA and L1 DNA as markers of residual\/recurrent cervical intraepithelial neoplasia","volume":"28","author":"Persson","year":"2012","journal-title":"Oncol. Rep."},{"key":"10.1016\/j.jcv.2015.10.027_bib0285","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1136\/jclinpath-2013-202014","article-title":"Evaluation of commercial HPV assays in the context of post-treatment follow-up: Scottish Test of Cure Study (STOCS-H)","volume":"67","author":"Cubie","year":"2014","journal-title":"J. Clin. Pathol."},{"key":"10.1016\/j.jcv.2015.10.027_bib0290","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1309\/AJCPHVD7MIP3FYVV","article-title":"Human Papillomavirus oncogenic mRNA testing for cervical cancer screening: baseline and longitudinal results from the CLEAR study","volume":"144","author":"Reid","year":"2015","journal-title":"Am. J. Clin. Pathol."},{"key":"10.1016\/j.jcv.2015.10.027_bib0295","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.jcv.2015.05.006","article-title":"The reliability of high-risk human papillomavirus detection by Aptima HPV assay in women with ASC-US cytology","volume":"69","author":"Castle","year":"2015","journal-title":"J. Clin. Virol."},{"key":"10.1016\/j.jcv.2015.10.027_bib0300","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1309\/AJCPLCD8TTOMLJTB","article-title":"Detection of human papillomavirus 16, 18, and 45 in women with ASC-US cytology and the risk of cervical precancer: results from the CLEAR HPV study","volume":"143","author":"Castle","year":"2015","journal-title":"Am. J. Clin. Pathol."},{"key":"10.1016\/j.jcv.2015.10.027_bib0305","first-page":"1411","article-title":"Human papillomavirus messenger RNA assay for cervical cancer screening: the Shenzhen Cervical Cancer Screening Trial I","volume":"20","author":"Wu","year":"2010","journal-title":"Int. J. Gynecol. Cancer"},{"key":"10.1016\/j.jcv.2015.10.027_bib0310","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1128\/JCM.02147-10","article-title":"Aptima HPV E6\/E7 mRNA test is as sensitive as Hybrid Capture 2 Assay but more specific at detecting cervical precancer and cancer","volume":"49","author":"Ratnam","year":"2011","journal-title":"J. Clin. Microbiol."},{"key":"10.1016\/j.jcv.2015.10.027_bib0315","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1002\/ijc.25726","article-title":"Evaluation of oncogenic human papillomavirus RNA and DNA tests with liquid-based cytology in primary cervical cancer screening: the FASE study","volume":"129","author":"Monsonego","year":"2011","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.jcv.2015.10.027_bib0320","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/j.ygyno.2012.01.002","article-title":"Risk assessment and clinical impact of liquid-based cytology, oncogenic human papillomavirus (HPV) DNA and mRNA testing in primary cervical cancer screening (the FASE study)","volume":"125","author":"Monsonego","year":"2012","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.jcv.2015.10.027_bib0325","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1097\/IGC.0b013e318280f3bc","article-title":"Primary cervical cancer screening and triage using an mRNA human papillomavirus assay and visual inspection","volume":"23","author":"Nieves","year":"2013","journal-title":"Int. J. Gynecol. Cancer"},{"key":"10.1016\/j.jcv.2015.10.027_bib0330","doi-asserted-by":"crossref","first-page":"e86835","DOI":"10.1371\/journal.pone.0086835","article-title":"Disagreement between human papillomavirus assays: an unexpected challenge for the choice of an assay in primary cervical screening","volume":"9","author":"Rebolj","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.jcv.2015.10.027_bib0335","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1128\/JCM.03066-13","article-title":"Comparison of commercial hybridization and automated transcription-mediated amplification modalities for detection of high-risk human papillomavirus nucleic acid","volume":"52","author":"Munson","year":"2014","journal-title":"J. Clin. Microbiol."},{"key":"10.1016\/j.jcv.2015.10.027_bib0340","doi-asserted-by":"crossref","first-page":"3033","DOI":"10.1158\/1055-9965.EPI-08-0508","article-title":"Comparison of predictors for high-grade cervical intraepithelial neoplasia in women with abnormal smears","volume":"17","author":"Szarewski","year":"2008","journal-title":"Cancer Epidemiol. Biomarkers Prev."},{"key":"10.1016\/j.jcv.2015.10.027_bib0345","doi-asserted-by":"crossref","first-page":"2179","DOI":"10.1016\/j.ejca.2013.01.018","article-title":"Comparison of human papillomavirus testing strategies for triage of women referred with low-grade cytological abnormalities","volume":"49","author":"Mesher","year":"2013","journal-title":"Eur. J. Cancer"},{"issue":"Suppl. 1","key":"10.1016\/j.jcv.2015.10.027_bib0350","doi-asserted-by":"crossref","first-page":"S55","DOI":"10.1016\/S1386-6532(09)70009-5","article-title":"Clinical performance of the APTIMA HPV Assay for the detection of high-risk HPV and high-grade cervical lesions","volume":"45","author":"Dockter","year":"2009","journal-title":"J. Clin. Virol."},{"key":"10.1016\/j.jcv.2015.10.027_bib0355","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/j.ygyno.2010.06.011","article-title":"Performance of p16INK4a-cytology, HPV mRNA, and HPV DNA testing to identify high grade cervical dysplasia in women with abnormal screening results","volume":"119","author":"Reuschenbach","year":"2010","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.jcv.2015.10.027_bib0360","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1128\/JCM.01674-10","article-title":"Performance of the Aptima high-risk human papillomavirus mRNA assay in a referral population in comparison with Hybrid Capture 2 and cytology","volume":"49","author":"Clad","year":"2011","journal-title":"J. Clin. Microbiol."},{"key":"10.1016\/j.jcv.2015.10.027_bib0365","doi-asserted-by":"crossref","first-page":"1052","DOI":"10.5858\/2010-0411-OAR","article-title":"Clinical performance of a human papillomavirus messenger RNA test (Aptima HPV Assay) on residual material from archived 3-year-old PreservCyt samples with low-grade squamous intraepithelial lesion","volume":"135","author":"Waldstrom","year":"2011","journal-title":"Arch. Pathol. Lab. Med."},{"issue":"144","key":"10.1016\/j.jcv.2015.10.027_bib0370","first-page":"e1-8","article-title":"APTIMA HPV assay performance in women with atypical squamous cells of undetermined significance cytology results","volume":"208","author":"Stoler","year":"2013","journal-title":"Am. J. Obstet. Gynecol."},{"key":"10.1016\/j.jcv.2015.10.027_bib0375","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1016\/j.jcv.2013.12.001","article-title":"Clinical performance of RNA and DNA based HPV testing in a colposcopy setting: influence of assay target, cut off and age","volume":"59","author":"Cuschieri","year":"2014","journal-title":"J. Clin. Virol."},{"key":"10.1016\/j.jcv.2015.10.027_bib0380","doi-asserted-by":"crossref","first-page":"287","DOI":"10.3802\/jgo.2014.25.4.287","article-title":"The clinical performance of APTIMA human papillomavirus and Hybrid Capture 2 assays in the triage of lesser abnormal cervical cytologies","volume":"25","author":"Guo","year":"2014","journal-title":"J. Gynecol. Oncol."},{"key":"10.1016\/j.jcv.2015.10.027_bib0385","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1309\/AJCP1REBI2UVBHMX","article-title":"Comparison of the Aptima and Cervista tests for detection of high-risk human papillomavirus in cervical cytology specimens","volume":"142","author":"Nolte","year":"2014","journal-title":"Am. J. Clin. Pathol."},{"key":"10.1016\/j.jcv.2015.10.027_bib0390","first-page":"192","article-title":"Evaluation of the human papillomavirus mRNA test for the detection of cervical lesions in Japan","volume":"36","author":"Nakayama","year":"2015","journal-title":"Eur. J. Gynaecol. Oncol."}],"container-title":["Journal of Clinical Virology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1386653215007362?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1386653215007362?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,17]],"date-time":"2018-09-17T20:24:01Z","timestamp":1537215841000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1386653215007362"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,3]]},"references-count":78,"alternative-id":["S1386653215007362"],"URL":"https:\/\/doi.org\/10.1016\/j.jcv.2015.10.027","relation":{},"ISSN":["1386-6532"],"issn-type":[{"value":"1386-6532","type":"print"}],"subject":[],"published":{"date-parts":[[2016,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A review of the clinical performance of the Aptima HPV assay","name":"articletitle","label":"Article Title"},{"value":"Journal of Clinical Virology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jcv.2015.10.027","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}]}}